O018/#482 Updated safety of lenvatinib + pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
Articles > Article · 2022
Authors: Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, Bradley Monk, Helen Mackay, Alessandro Santin, David Miller, Richard Moore, Isabelle Ray-Coquard, Ronnie Shapira-Frommer, Kimio Ushijima, K.a.n. Yonemori, Yong Man Kim, Eva Guerra Alia, Ulus Ali ŞANLI, R.a.n. Xie, Melissa Zale, Jodi Mckenzie, Gianmaria Barresi, Domenica Lorusso
International Journal of Gynecological Cancer, International, WoS, 2022, vol 32, pp A11-A11